Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Mahendra S Rao

Mahendra S Rao

Q Therapeutics, Inc., USA

Paul J Davis

Paul J Davis

Albany College of Pharmacy and Health Sciences, USA

Bakhos A Tannous

Bakhos A Tannous

Harvard Medical School, USA

Brian Mehling

Brian Mehling

Blue Horizon International LLC, USA

Margarita Glazova

Margarita Glazova

Russian Academy of Science, Russia

Aletta Schnitzler

Aletta Schnitzler

EMD Millipore Corporation, USA

Vincent S Gallicchio

Vincent S Gallicchio

Clemson University, USA

Yael Porat

Yael Porat

BioGenCell, Ltd, Israel

Stem Cell Research 2018


Track 1:Stem Cells

Stem Cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells

 Stem Cell and Regenerative Medicine, September 25-26, 2017, Berlin, Germany;  Cell therapy and Molecular Medicine, September 27-28, 2017, Chicago, Illinois, USA; Cell Signaling and cancer Therapy, September 27-28, 2017, Chicago, Illinois,USA; ; Cancer therapy and Radiation oncology , August 28th, 29, 2017 Brussels, Belgium Tissue Engineering and Regenerative Medicine, August 23-24, 2017 San Francisco, California, USA; Wisconson Stem Cell Symposium, April 19, 2017, Wisconsin; 18th International Congress of Developmental Biology, June  18 - 22 , 2017, Singapore; Germinal Stem Cell Biology, June 18-23, 2017, Hong Kong, China; Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases, July 24-27, 2017, Vermont, Burlington, VT; Advances in Stem Cells and Regenerative Medicine, May 23 - 26, 2017, Heidelberg, Germany.

Track 2:Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but sometherapies derived from umbilical cord blood are also in use.

 Cell therapy and Molecular Medicine, September 27-28, 2017, Chicago, Illinois, USA;  Molecular Genetics and Gene Therapy, July 03-05, 2017 Thailand, Bangkok; Cell and Gene therapy, March 26-27, 2017 Berlin, Germany; 25th  World Congress on Cancer Therapy, Oct 18-20, 2017, Baltimore, USA; Stem Cell and Regenerative Medicine, September 25-26, 2017, Berlin, Germany; Wisconson Stem Cell Symposium, April 19, 2017, Wisconsin; Advances in Stem Cells and Regenerative Medicine, May 23 - 26, 2017, Heidelberg, Germany; Managing Cell and Human Identity, April 16, 2017, Pennsylvania, USA;

Track 3:Stem Cell Apoptosis And Signal Transduction

Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.

Stem Cell and Regenerative Medicine, September 25-26, 2017, Berlin, Germany; Integrative Biology, June 19-21, 2017, London, UK; Systems and Synthetic Biology, July 20-21, 2017, Munich, Germany; Genomics and Pharmacogenomics, June 15-16, 2017, London, UK;  Tissue Preservation and Biobanking, August 23-24, 2017, San francisco, Californis, USA; 3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences, February 11, 2018, Cancun, Mexico; Molecular and Cell Biology of Membranes, May 21-23, 2017, Heidelberg, Germany; Mitochondrial Biogenesis and Dynamics in Health, Disease and Aging, May 21-26, 2017, Florida, US;  Cell Death and Inflammation, May 29 - June02, 2017, Dublin, Ireland; Rapid Signaling and Genomic Steroid Hormone Actions in Health and Disease, June11-16, 2017, Colorado, US

Track 4:Stem Cell Transplantation

Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.

Molecular Genetics and Gene Therapy, July03-05, 2017, Thailand, Bangkok; Human Genetics, September 14-15, 2017 Edinburgh, Scotland; Systems and Synthetic Biology, July 20-21, 2017 Munich, Germany; Integrative Biology, June 19-21, 2017, London, UK; Tissue Engineering and Regenerative Medicine, August 23-24 , 2017 San Francisco, California ,USA; Signal Transduction in the Immune System, June 18-23, 2017, Colorado, USA; The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine, June 19-24, 2017, Dubrovnik, Croatia; Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology , March 19-23,2017, Whistler, Canada; Managing Cell and Human Identity, April 26, 2017, Philadelphia, U.S.

Track 5:Cell Signaling In Development

Cell signaling mediated by morphogens is essential to coordinate growth and patterning, two key processes that govern the formation of a complex multi-cellular organism. During growth and patterning, cells are specified by both quantitative and directional information. While quantitative information regulates cell proliferation and differentiation, directional information is conveyed in the form of cell polarities instructed by local and global cues

Cell Signaling and cancer Therapy, September 27-28, 2017, Chicago, Illinois,USA; Gynecologic Oncology, July 20-21, 2017, Chicago, Illinois, USA; Oncologist & Diagnostics Conference, August 28-30, 2017, Brussels, Belgium; Leukemia and Hematologic Oncology, October 05-06, 2017, London,UK;  Stem Cell and Regenerative Medicine, September 25-26, 2017, Berlin, Germany; Targeting Cancer Metabolism and Signaling , May 25, 2017, Newyork, US; NAD + Metabolism & Signaling 2017, July 09-14, 2017,  Louisiana, United States; Protein Kinases and Protein Phosphorylation, August 06-11, 2017, Cambridge, UK;  3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences, February 11-15, 2017, Cancun, Mexico

Track 6:Stem Cell Embryology

Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with Embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of somatic cell.

Gynecology & Obstertrics, October 02-04, 2017 Barcelona, spain; 3rd Annual Conference on Gynecologic Oncology, July 20-21, 2017, Chicago, USA;  Stem Cell and  Biobanking, October 23-24, 2017 Osaka, Japan,  Cancer science and therapy, Baltimore, Maryland, USA, oct ber18 - 20, 2017; 2nd DNA Replication as a Source of DNA Damage Conference, July 03-06, 2017, Rome italy; Advances in Stem Cells and Regenerative Medicine, May 23 - 26, 2017, Heidelberg, Germany; Managing Cell and Human Identity, April 16, 2017, Pennsylvania, USA

Track 7:Regeneration And Therapeutics

Regeneration is the process of renewal, restoration, and growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Therapeutics is  the branch of medicine concerned with the treatment of disease and the action of remedial agents.

Cancer therapy and Radiation oncology , August 28th, 29, 2017 Brussels, Belgium; Gastrointestinal and cancer therapeutics, Baltimore, USA october  16-18, 2017; Cancer science and therapy, Baltimore, Maryland, USA, oct ober18 - 20, 2017;  Cell biology of the neuron: Polarity, plasticity and regeneration, May 07-10, 2017, Heraklion, Greece;  Annual Congress On Cell Science, Stem Cell Biology And Therapeutics 2017, November 16-17, 2017, Atlanata, US; Signal Transduction in the Immune System, June 18-23, 2017, Colorado, USA; World Advanced Therapies & Regenarative Medicine, May, 17-19, 2017, London,  UK; World Stem Cell and Regenerative Medicine, August 07-09, 2017, Sweden; Tissue Repair & Regeneration, June 4-9, 2017, New London

Track 8:Tissue Engineering:

Tissue engineering can be defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to improve clinica l procedures for the repair of damaged tissues and organs.

Tissue Engineering and Regenerative Medicine, August 23-24, 2017 San Francisco, California, USA; Tissue Preservation and Biobanking, August 23-24, 2017, San francisco, Californis, USA; Tissue Science and Regenerative Medicine, October 02-04, 2017 Barcelona, Spain; Solicitation of Proposals for the TERMIS-AM 2020 Conference, July 31, 2017, 

Track 9:Diseases And Stem Cell Treatment:

Stem cell research is perhaps the most exciting medical technology of the 21st Century. Stem cells hold the promise of treatments and cures for more than 70 major diseases and conditions that affect millions of people, including diabetes, Parkinson's, Alzheimer's, cancer, multiple sclerosis, Lou Gehrig's Disease (ALS), spinal cord injuries, blindness, and HIV/AIDS.

Track 10:Novel Stem Cell Technologies:

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self renewal and multilineage  differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation

Track 11:Reprogramming Stem Cells: Computational Biology:

Computational biology, a branch of biology involving the application of computers and computer science to the understanding and modeling of the structures and processes of life. It entails the use of computational methods  for the representation and simulation of biological systems, as well as for the interpretation of experimental data, often on a very large scale. The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency.  In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies

Cancer genetics and Epigentics, October 26-28, Osaka, Japan;  Epigenetics & Chromatin , Noveber 06-08, 2017 Frankfurt, Germany

Track 12:Tumour cell science:

Cancer cells are cells gone wrong  in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow and divide, they diverge ever further from normalcy. Over time, these cells become increasingly resistant to the controls that maintain normal tissue and as a result, they divide more rapidly than their progenitors and become less dependent on signals from other cells. Cancer cells even evade programmed cell death, despite the fact that their multiple abnormalities would normally make them prime targets for apoptosis. In the late stages of cancer, cells break through normal tissue boundaries and metastasize to new sites in the body.

Oncology & Cancer , May 25-27, 2017 Osaka, Japan;  Cancer Diagnostics, November 27-28, 2017 Dubai, UAE; Cancer Science and Therapy, July 17-19, 2017 Libson, Portugal; Cancer Biology R&D and Market, September 18-19, 2017 Philadelphia, Pennsylvania, USa;  26th word Cancer Convention, November 27-28, 2017 Dubai, UAE;

Track 13:Stem Cell Banking:

An amniotic stem cell bank is a facility that stores stem cells derived from amniotic fluid for future use. Stem cell samples in private  banks are stored specifically for use by the individual person from whom such cells have been collected and the banking costs are paid by such person

 Stem Cell and  Biobanking, October 23-24, 2017 Osaka, Japan;  Tissue Preservation and Biobanking, August 23-24, 2017, San francisco, Californis, USA; 11th International Conference on Hematology and Hematological Oncology, November 8-9, 2017, Las Vegas, USA, 

Track 14:Cellular Plasticity And Reprogramming:

Stem cell plasticity refers to the ability of some stem cells to give rise to cell types, formerly considered outside their normal repertoire of differentiation for the location where they are found. Included under this umbrella title is often the process of “transdifferentiation” – the conversion of one differentiated cell type into another, and metaplasia – the conversion of one tissue type into another. 

Track 15:Epigenetics:

The study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. Epigenetics are stable heritable traits  that cannot be explained by changes in DNA sequence

Cancer genetics and Epigentics, October 26-28, Osaka, Japan;  Epigenetics & Chromatin , Noveber 06-08, 2017 Frankfurt, Germany; World Congress on Preventive oncology, July 20-21, 2017, Chicago, USA; 

Track 16:Cell And Gene Therapy:

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery

Cell therapy and Molecular Medicine, September 27-28, 2017, Chicago, Illinois, USA;  Molecular Genetics and Gene Therapy, July 03-05, 2017 Thailand, Bangkok; Cell and Gene therapy, March 26-27, 2017 Berlin, Germany; 25th  World Congress on Cancer Therapy, Oct 18-20, 2017, Baltimore, USA; Stem Cell and Regenerative Medicine, September 25-26, 2017, Berlin, Germany; Wisconson Stem Cell Symposium, April 19, 2017, Wisconsin; Advances in Stem Cells and Regenerative Medicine, May 23 - 26, 2017, Heidelberg, Germany; Managing Cell and Human Identity, April 16, 2017, Pennsylvania, USA;

Track 17:Stem Cell Biomarkers:

Stem cell markers are genes and their protein products used by scientists to isolate and identify stem cells. Stem cells can also be identified by functional assays. Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery

Biomarkers, October 26-28, 2017 Osaka, Japan;  9th World Biomarkers Congress, August 24-25, 2017 Birmingham, UK; 10th  Annual World Congress on Biomarkers & Clinical Research, October 18-20, 2017, Baltimore, USA; 

Track 18:Cell And Organ Regeneration:

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.

Tissue Repair & Regeneration, June 4-9, 2017, New London; The Biologyof Regenerative Medicine, April 25-27, 2017  Hinxton, Cambridge, UK; Innovations In Cancer Research and Regenerative Medicine, September 10-13, 2017, Ho Chi Minh city, Viet Nam; International Symposium On Regenerative Rehabilation, November 1-3, 2017, Pittsburgh, USA; Mouse Development, Stem Cells & Cancer, June 7 - 26, 2017, Newyork

Track 19:Stem Cell Niches:

Stem-cell niche refers to a microenvironment, within the specific anatomic location where stem cells are found, which interacts with stem cells to regulate cell fate. The word 'niche' can be in reference to the in vivo or in vitro stem-cell microenvironment.During embryonic development, various niche factors act on embryonic stem cells to alter gene expression, and induce their proliferation or differentiation for the development of the fetus.

Track 20:Drugs And Clinical Developments:

The clinical development plan is a complex document that entails the entire clinical research strategy of a drug, describing the clinical studies that will be carried out for a pharmaceutical entity, created by a pharmaceutical company

Track 21:Stem Cells And Veterinary Applications:

The stem cell field in veterinary medicine continues to evolve rapidly both experimentally and clinically. Stem cells are most commonly used in clinical veterinary medicine in therapeutic applications for the treatment of musculoskeletal injuries in horses and dogs. New technologies of assisted reproduction are being developed to apply the properties of spermatogonial stem cells to preserve endangered animal species.same methods can be used to generate transgenic animals for production of pharmaceuticals or for use as biomedical models

Animal and Human Cell Culture, September 25-27, 2017 Jackson ville, USA; Animal Health & Veterinary Medicine, October 20-21, 2017 toronto, Canada, 

Track 22:Plant And Cell Physiology:

Cell physiology including cellular electrophysiology is the biological study of the activities which take place in a cell to keep it alive. The term "physiology" refers to all the normal functions that take place in a living organism. Absorption of water by roots, production of food in the leaves, and growth of shoots towards light are examples of plant physiology. The heterotrophic metabolism of food derived from plants and animals and the use of movement to obtain nutrientsare characteristic of animal physiology

Plant Genomics, July 03-05, 2017 Bangkok, Thailand;  Medicinal Plants and Natural Products Research, October 02-03, 2017 Kuala Lumpur,Malaysia; Plant Science &Physiology, June 26-18, 2017 Bangkok, Thailand; Plant Science, Aug 07-09, 2017 Rome, Italy;  Agriculture & Horticulture, Oct 02-04, 2017 London, UK

Track 23:Cell Differentiation And Disease Modelling:

disease model is an animal or cells displaying all or some of the pathological processes that are observed in the actual human or animal disease. Studying disease models aids understanding of how the disease develops and testing potential treatment approaches

Drug Design& Drug Formulation, Oct19-20,2017 Seoul, South Korea;  Normal and cancer stem cells: discovery, diagnosis and therapy October 5-6, 2017, Kyiv, Ukraine

Track 24:Stem Cell Medicine: Social And Political Challenges:

The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years.

About Conference

ConferenceSeries Ltd  invites all the participants from all over the world to attend '10th World Congress on Cell & Stem Cell Research’ during March 19-21, 2018 in New York, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Stem cells are cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans there are several types of stem cells, each with variable levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age.


Stem Cell Research-2018 has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Stem Cell Research 2018 will have an anticipated participation of 120+ delegates across the world to discuss the conference goal.

Success Story: Cell Science Conference Series

The success of the Cell Science conference series has given us the prospect to bring the gathering in New YorkUSA. Since its commencement in 2011 Cell Science series has witnessed around 750 researchers of great potentials and outstanding research presentations from around the world. Awareness of stem cells and its application is becoming popular among the general population. Parallel offers of hope add woes to the researchers of cell science due to the potential limitations experienced in the real-time.

About Organizers

ConferenceSeries Ltd  is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia  ConferenceSeries Ltd  has so far organized 3000+ Global Conferenceseries  Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology. OMICS International is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.

Scientific Sessions

Stem Cell Research-2018 will encompass recent researches and findings in stem cell technologies, stem cell therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in stem cell research and cell science. Stem Cell Research-2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Research-2018 will focus on the latest and exciting innovations in prominent areas of cell science and stem cell research.

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience.

Market Analysis

10th World Congress on Cell & Stem Cell Research

The success of the 9 Cell Science conferences series has given us the prospect to bring the gathering one more time for our 10th World Congress 2018 meet in New York, USA. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time

Stem Cell Research-2018 has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need. World Congress 2018 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal

History of Stem cells Research        

Stem cells have an interesting history, in the mid-1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood
1981: First in vitro stem cell line developed from mice
1988: Embryonic stem cell lines created from a hamster
1995: First embryonic stem cell line derived from a primate
1997: Cloned lamb from stem cells
1997: Leukaemia origin found as haematopoietic stem cell, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cell research in the United States, but only placed restrictions on funding and use, under Congress's power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of human embryonic stem cells. Prior to President Obama's executive order, federal funding was limited to non-embryonic stem cell research and embryonic stem cell research based upon embryonic stem cell lines in existence prior to August 9, 2001. In 2011, a United States District Court "threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research”.

Members Associated with Stem Cell Research:

     Discussion on Development, Regeneration, and Stem Cell Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cell Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and “evo-devo” (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Cell Therapy Market, By Region, 2009 2018



Figure 1: Market by Geography

Why to attend???

Stem Cell Research-2018 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference. 

A Unique Opportunity for Advertisers and Sponsors at this International event:

UAS Major Universities which deals with Stem Cell Research 

·         University of Washington/Hutchinson Cancer Center

·         Oregon Stem Cell Center

·         University of  California Davis

·         University of  California San Francisco

·         University of California Berkeley

·         Stanford University

·         Mayo Clinic

Major Stem Cell Organization Worldwide:

·         Norwegian Center for Stem Cell Research

·         France I-stem

·         Stem Cell & Regenerative Medicine Ctr, Beijing

·         Stem Cell Research Centre, Korea

·         NSW Stem Cell Network

·         Monash University of  Stem Cell Labs

·         Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

 Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.


Figure 2: Global Market

Companies working for Stem Cells:



Business Type

Cynata Therapeutics

Armadale, Australia

Stem Cell Manufacturing Technology


Melbourne, Australia

Regenerative Medicine


Vienna, Austria

Dendritic Cell-Based Cancer Immunotherapy


Vienna, Austria

Treatments composed of mixture of cytokines, growth factors and other active components

Cardio3 Biosciences

Mont-Saint-Guibert, Belgium

Stem Cell Differentiation

Orthocyte (BioTime)

Alameda, CA

Cellular Therapies


Beverly Hills, CA

Stem Cell Heart Treatments

Life Stem Genetics

Beverly Hills, CA

Autologous stem cell therapy

International Stem Cell

Carlsbad, CA

Proprietary Stem Cell Induction


Carlsbad, CA

Cell Therapy

DaVinci Biosciences

Costa Mesa, CA

Cellular Therapies

Invitrx Therapeutics

Irvine, CA

Autologous Stem Cell Therapy, Therapeutic & Cosmetic

General Trends within the Stem Cell Sector

Figure 3: This Statistics shows that Most popular sources of stem cells are adult bone marrow/blood and neural tissues

Stem Cell Software’s :

  1. Cryus : Cryus is developed specially for Cord Blood Banks, Donor Centers, Stem Cells Collection Centers, Biotech Laboratories and Tissue Banks.
  2. Label-InnThe: Which allows to record the donor or the patient personal data into the database and generates the Donation Identification Number (DIN) according to ICCBBA international standard ISBT128. It serves as labelling software for blood samples and Stem Cells products.

Products Manufactured By Industry Related to Stem Cell:

RoboSep™-16 is the latest RoboSep™ instrument ingenuous for performing fully-automated cell separation from a huge number of samples. Using EasySep™, the column-free immunomagnetic cell separation system, RoboSep™-16 isolates desired cells from a wide range of samples from different species, tissue sources or sizes using positive or negative selection. Through an intuitive user interface, the RoboSep™-16 simultaneously isolates cells from up to sixteen samples with minimal hands on time. By automating all reagent and sample handling steps, and through the use of disposable pipette tips, the RoboSep™-16 rapidly isolates all desired cells while minimizing the risk of sample cross-contamination. After completion of the cell isolation procedure, cells of interest are immediately available for any downstream application.

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single cell suspensions of splenocytes or other tissues by positive selection. Desired cells are labeled with antibodies and magnetic particles.  The cells are separated without columns using an EasySep™ magnet.  Unwanted cells are simply poured off, while desired cells remain in the tube.  Isolated cells are immediately ready for downstream applications such as flow cytometry, cell culture, or suppression assays.

Featured Research:

       Gene therapy gives assurance for severe combined immunodeficiency, Researchers have initiated that gene therapy using a improved delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially efficacious, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.




Past Conference Report

Stem Cell Research 2017

The success of the 7th Cell Science conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “8th World Congress and Expo on Cell and Stem Cell Research” during March 20-22, 2017 at Hotel Holiday Inn, Orlando Airport, Orlando, Florida, USA. The conference was focused on Cell Biology and Stem Cell Research studies with the theme “Explore and Exploit the Novel Techniques in Cell and Stem Cell Research”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Stem Cell Therapy, Drugs and Clinical Developments, Stem Cell Transplantation, Current Research, Research and Development: Instrumentation, Genetics & Genomics, Cell based Therapies of Blood Diseases: Malignant and Non-Malignant & Cell Line Development, Novel Stem Cell Technologies, Cell Mechanics, Apoptosis and Cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Paul J. Davis, Albany Medical College, USA

Haval Shirwan, University of Louisville, USA

Diana Anderson, University of Bradford, UK

Georg F. Weber, University of Cincinnati, USA

Bakhos A Tannous, Harvard Medical School, USA

Mahendra S.Rao, Q Therapeutics, Inc., USA

Best Poster Awardees:

Title: Effect of ionizing radiation on the proliferation of human embryonic stem cells

Irina V Panyutin, National Institute of Health, USA

Title: Manipulation of adult stem cells plasticity with modulators of chromatin modifying enzymes

Arshak R Alexanian, Cell Reprogramming & Therapeutics LLC, USA

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with the organisation and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Stem Cell Research-2017, Conferenceseries LLC  would like to announce the commencement of the “10th  World Congress on Cell and Stem Cell Research” to be held in March 2018 at New York, Washington, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cell Science Research.

Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 19-21, 2018

For Sponsors & Exhibitors

Speaker Opportunity

Day 1 Day 2 Day 3

Supported By

Journal of Cell Science & Therapy Journal of Stem Cell Research & Therapy Cell & Developmental Biology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by

What People Say....

Thank you for your kind letter. I enjoyed the meeting and the opportunity to exchange ideas with other researchers. Best wishes Kenneth K. Wu, MD. PhD. National Taiwan University, Taipei, Taiwan

I have received very positive feedback from Chen Shen who presented our work in Chicago. He got in contact with many different people interested in our research. Thus, i am very glad to accept your kind invitation to the next Conference in San Francisco. Thank you.. Simon Berkovich The George Washington University, USA

Dear Jessie, From what I have seen, the organization was very good. I am always impressed by the quality of presenters and the opportunity for contacts that can be made at the OMICS conferences. Thank you for your support. Christian Drapeau Stemtech International, Inc., USA

I would be very pleased to help out with the 2016 Congress on Cell and Stem Cell Research in San Francisco. The recent Congress in Chicago was, from the scientific standpoint, the highest quality and most useful of the three OMICS-sponsored conferences that I have attended. The presentations I heard were uniformly good. Paul J. Davis, MD Albany Medical College, USA

I just want to say how much I enjoyed the meeting in Chicago. I always find the meetings extremely stimulating and very interactive. The quality of the presentations is very good and some of them are very thought-provoking. In general, all your meetings I attend are of high quality. I hope to come to San Francisco next year. Diana Anderson University of Bradford, UK


  • Automated Robotic Stem Cell Derivation
  • Cardiac Cell Differentiation
  • Cell Lineage Specification
  • Cell Replacement Therapies For Diabetes
  • Cell Specification And Differentiation
  • Characterization Of Stem Cell Derived Pancreatic Beta Cells In The Context Of Disease Modeling
  • Extrinsic Regulation Of Stem Cells
  • Hematopoietic Malignancies
  • Hematopoietic Stem Cell Biology
  • Hematopoietic Stem Cell Biology
  • Human Embryonic And Induced Pluripotent Stem Cells For Reconstructive Therapies Of The Skeletal System
  • Induced Pluripotent Stem Cell Derivation
  • Innovative Stem Cell Technologies
  • Modeling Cardiac Diseases Using Stem Cells
  • Models Of Psychiatric Illness
  • Multiple Myeloma
  • Myeloid Malignancies
  • Myogenic Stem Cells
  • Neural Degeneration And Repair
  • Neuronal Migration
  • Replacement Therapies For Parkinsons Disease
  • Stem Cell Biology
  • Stem Cell Niche
  • Stem Cells In Tissue Homeostasis And Aging
  • Stem Cells To Treat Cronic Myelogoneys Leukemia
  • Stem Cells To Treat Heart Failure
  • Synaptic Specificity
  • Treatment Of Burns
  • Treatment Of Cardiovascular Disease
  • TSCs Quiescent
  • Vascular Tissue Engineering With Bone Marrow Stem Cells